A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye

Journal of Controlled Release

Volumn 44, Issue 2-3, 1997, Pages 201-208

  Cohen, Smadar ^a   Lobel, Esther ^b   Trevgoda, Amira ^a   Peled, Yael ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

^b TEVA PHARMACEUTICALS   (Israel)

Author keywords

alginate vehicle; in situ gelation; intraocular pressure; ophthalmic delivery; pilocarpine

Indexed keywords

ALGINIC ACID; DRUG CARRIER; EYE DROPS; GULURONIC ACID; MANNURONIC ACID; PILOCARPINE; POLYMER; PROTONAL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; AQUEOUS SOLUTION; ARTICLE; CONTROLLED STUDY; DIFFUSION; DISSOLUTION; DOSE TIME EFFECT RELATION; DRUG DELIVERY SYSTEM; DRUG RELEASE; FEMALE; INTRAOCULAR PRESSURE; LACRIMAL FLUID; LIQUID; NONHUMAN; PHASE TRANSITION; PRIORITY JOURNAL; RABBIT; SUSTAINED RELEASE FORMULATION;

EID: 0031575549     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-3659(96)01523-4     Document Type: Article

References (16)

1. J.W. Sieg and J.R. Robinson, Mechanistic studies of transcorneal permeation of pilocarpine. J. Pharm. Sci. 65 (1976) 1816-1822.
2. V.H.L. Lee and J.R. Robinson, Mechanistic and quantitative evaluation of percorneal pilocarpine distribution in albino rabbits. J. Pharm. Sci. 68 (1979) 673-684.
3. H.S. Brown, G. Meltzer, R.C. Merril, M. Fisher, C. Ferre and U.A. Place, Visual effects of pilocarpine in glaucoma. Comparative study of administration of eye drops or by ocular therapeutic systems. Arch. Ophthalmol. 94 (1976) 1716-1719.
4. A.K. Mitra, Ophthalmic Drug Delivery Systems, Marcel Dekker, New York, 1993.
5. S.C. Miller and M.D. Donovan, Effect of Poloxamer 407 gel on the mitotic activity of pilocarpine nitrate in rabbits. Int. J. Pharm. 12 (1982) 147-152.
6. M. Vadnere, G. Amidon, S. Lindenbaum and J.L. Haslam, Thermodynamic studies on the gel-sol transition of some pluronic polyols. Int. J. Pharm. 22 (1984) 207-218.
7. R. Gurny, T. Boye and H. Ibrahim, Ocular therapy with nanoparticulate systems for controlled drug delivery. J. Control. Rel. (1985) 353-361.
8. A. Rozier, C. Mazuel, J. Grove and B. Plazonnet, Gelrite®: A novel, ion-activated, in-situ gelling polymer for ophthalmic vehicles. Effect on bioavailability of timolol. Int. J. Pharm. 57 (1989) 163-168.
9. G.T. Grant, E.R. Morris, D.A. Rees, P.J.C. Smith and D. Thom, Biological interactions between polysaccharides and divalent cations: The egg box model. FEBS Lett. 32 (1973) 195-198.
10. T. Matsumoto, M. Kawai and T. Masuda, Viscoelastic and SAXS investigation of fractal structure near the gel point in alginate aqueous systems. Macromolecules 25 (1992) 5430-5433.
11. A. Martinsen, G. Skjåk-Braek and O. Smidsrød, Alginate as immobilization material: I. Correlation between chemical and physical properties of alginate gel beads. Biotechnol. Bioeng. 33 (1989) 79-89.
12. P.-H. Chung, T.-F. Chin and J.L. Lach, Kinetics of the hydrolysis of pilocarpine in aqueous solution. J. Pharm. Sci. 59 (1970) 1300-1306.
13. N.J. Van Haeringen, Clinical biochemistry of tears. Survey Ophthalmol. 26 (1981) 84-95.
14. A.J. King, A.J. Daugulis, D.P. Faulker and M.F.A. Goosen, Alginate-Polylysine microcapsules of controlled membrane molecular weight cutoff for mammalian cell culture engineering. Biotech. Prog. 3 (1987) 231-240.
15. S. Cohen, M.C. Bano, M. Chow and R. Langer, Lipid-alginate interactions render changes in phospholipid bilayer permeability. Biochim. Biophys. Acta. 1063 (1991) 95-102.
16. P.M. Huges and A.K. Mitra, Overview of ocular drug delivery and intragenic ocular cytopathologies. In: A.K. Mitra (Ed.) Ophthalmic Drug Delivery Systems, Marcel Dekker, Inc., New York, 1993, pp. 1-27.